Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating vitiligo and preparation method thereof

A composition and vitiligo technology, applied in the direction of drug combination, pharmaceutical formula, medical preparations containing active ingredients, etc., can solve patients' heavy psychological pressure and mental burden, family, work and social influence, treatment difficulties and other problems

Inactive Publication Date: 2016-02-03
JINAN XINGYI MEDICAL TECH
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The disease is easy to diagnose but difficult to treat
As there is currently no effective treatment for this disease, and the course of treatment is relatively long, it causes heavy psychological pressure and mental burden to the patients. After the disease, not only family, work and social interaction are affected, but some people even commit suicide due to long-term psychological depression.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating vitiligo and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Embodiment 1: the pharmaceutical composition for the treatment of vitiligo and its preparation method

[0031] The composition and parts by weight of the crude drug of the medicinal composition for treating vitiligo are as follows: 130g of willow leaf glycyrrhizin, 110g of alfalfa, 110g of egg ginseng, 90g of wet raw hypericin B6g, 3g of high psyllidin, 2.5g of southern kauri biflavone;

[0032] Preparation method: take alfalfa, egg ginseng, willow-leaf glycyrrhizin, hypericin B, high psyllogen, and southern kauri biflavone according to the ratio of raw materials, mix them, and use 30% ethanol by weight As a solvent, extract by warm dipping at 45°C, the number of extractions is 6 times, and the extraction time is 4 hours each time, and the amount of solvent used each time is 20 times the total weight of the raw material drug, and filtered to obtain medicinal residue A and the extract, the extract Recover ethanol, concentrate to a relative density of 1.09, filter, the dr...

Embodiment 2

[0033] Embodiment 2: the pharmaceutical composition for the treatment of vitiligo and its preparation method

[0034] The composition and parts by weight of the crude drug of the medicinal composition for treating vitiligo are: willow leaf glycyrrhizin 140g alfalfa 100g egg ginseng 100g wet raw hypericin B5g high psyllidin 4g southern kauri biflavone 2g;

[0035] Preparation method: take alfalfa, egg ginseng, willow-leaf glycyrrhizin, hypericin B, high psyllogen, and southern kauri biflavone according to the ratio of raw materials, mix them, and use 30% ethanol by weight As a solvent, extract by warm dipping at 45°C, the number of extractions is 6 times, and the extraction time is 4 hours each time, and the amount of solvent used each time is 20 times the total weight of the raw material drug, and filtered to obtain medicinal residue A and the extract, the extract Recover ethanol, concentrate to a relative density of 1.09, filter, the drug solution passes through the YWD01G3 mac...

Embodiment 3

[0036] Embodiment 3: the pharmaceutical composition for the treatment of vitiligo and its preparation method

[0037] The composition and parts by weight of the raw material drug of the medicinal composition for treating vitiligo are: 120g of willow leaf glycyrrhizin, 120g of alfalfa, 120g of egg ginseng, 80g of wet raw hypericin B7g, 2g of high psyllidin, 3g of southern kauri flavonoids;

[0038] Preparation method: take alfalfa, egg ginseng, willow-leaf glycyrrhizin, hypericin B, high psyllogen, and southern kauri biflavone according to the ratio of raw materials, mix them, and use 30% ethanol by weight As a solvent, extract by warm dipping at 45°C, the number of extractions is 6 times, and the extraction time is 4 hours each time, and the amount of solvent used each time is 20 times the total weight of the raw material drug, and filtered to obtain medicinal residue A and the extract, the extract Recover ethanol, concentrate to a relative density of 1.09, filter, the drug so...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating vitiligo and a preparation method thereof. The pharmaceutical composition is prepared by taking tabersonine, medicago ruthenica, codonopsis convolvulacea Kurz., uliginosin B, homoplantaginin and robustaflavone as raw medicinal materials, and matching; the composition can be prepared into various dosage forms according to conventional preparation technologies, and is effective in treatment of vitiligo.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a medicinal composition for treating vitiligo and a preparation method thereof. Background technique [0002] Vitiligo is a common clinical depigmentation skin disease. It is mainly caused by the reduction or disappearance of local skin melanocytes. Mostly manifested as local skin lightening, whitening, disappearance of pigment, and clear state. Although there is no subjective symptom, it affects beauty. Vitiligo often appears in areas where pigment is relatively easy to deposit, such as the face, especially around the eyes or mouth, armpits and groin areas. Lesions are also common in areas prone to trauma or friction, such as the extremities, elbows, knees, and ankles. In mild cases, only local skin lesions appear, and in severe cases, the lesions can be combined into sheets. The incidence of this disease does not distinguish between race an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/48A61P17/00A61K31/7048A61K31/437A61K31/352
Inventor 邵培财
Owner JINAN XINGYI MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com